These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8725101)

  • 41. Antibody responses determined for Japanese dengue fever patients by neutralization and hemagglutination inhibition assays demonstrate cross-reactivity between dengue and Japanese encephalitis viruses.
    Yamada K; Takasaki T; Nawa M; Yabe S; Kurane I
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):725-8. PubMed ID: 12853413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus.
    Wang B; Hua RH; Tian ZJ; Chen NS; Zhao FR; Liu TQ; Wang YF; Tong GZ
    Virus Res; 2009 Apr; 141(1):90-5. PubMed ID: 19185592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses.
    Konishi E; Shoda M; Ajiro N; Kondo T
    J Clin Microbiol; 2004 Nov; 42(11):5087-93. PubMed ID: 15528700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases.
    Jan LR; Yang CS; Trent DW; Falgout B; Lai CJ
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():573-80. PubMed ID: 7897348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice.
    Konishi E; Terazawa A; Imoto J
    Vaccine; 2003 May; 21(17-18):1826-32. PubMed ID: 12706666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
    Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
    Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute undifferentiated fever caused by infection with Japanese encephalitis virus.
    Watt G; Jongsakul K
    Am J Trop Med Hyg; 2003 Jun; 68(6):704-6. PubMed ID: 12887030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies to Japanese encephalitis virus in human sera collected from Irian Jaya. Follow-up of a previously reported case of Japanese encephalitis in that region.
    Spicer PE; Phillips D; Pike A; Johansen C; Melrose W; Hall RA
    Trans R Soc Trop Med Hyg; 1999; 93(5):511-4. PubMed ID: 10696406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
    Falconar AK
    Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.
    Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
    J Med Virol; 2000 Oct; 62(2):224-32. PubMed ID: 11002252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand.
    Edelman R; Schneider RJ; Chieowanich P; Pornpibul R; Voodhikul P
    Southeast Asian J Trop Med Public Health; 1975 Sep; 6(3):308-15. PubMed ID: 176736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of host virus-reactive antibodies in blood meals of naturally engorged mosquitoes.
    Barbazan P; Palabodeewat S; Nitatpattana N; Gonzalez JP
    Vector Borne Zoonotic Dis; 2009 Feb; 9(1):103-8. PubMed ID: 18973442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serosurveillance for Japanese encephalitis in children in several districts of West Bengal, India.
    Chatterjee S; Chattopadhyay D; Bhattacharya MK; Mukherjee B
    Acta Paediatr; 2004 Mar; 93(3):390-3. PubMed ID: 15124845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations.
    Konishi E; Suzuki T
    Vaccine; 2002 Nov; 21(1-2):98-107. PubMed ID: 12443667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes in dengue and Japanese encephalitis (JE) antibody after JE vaccination.
    Quina MA; Thein S; Auvanich W; Okuno Y; Igarashi A; Fukai K
    Biken J; 1978 Dec; 21(4):149-59. PubMed ID: 754688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
    Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
    Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-reactive IgM responses in patients with dengue or Japanese encephalitis.
    A-Nuegoonpipat A; Panthuyosri N; Anantapreecha S; Chanama S; Sa-Ngasang A; Sawanpanyalert P; Kurane I
    J Clin Virol; 2008 May; 42(1):75-7. PubMed ID: 18304870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of flavivirus antibodies in human serum by epitope-blocking immunoassay.
    Burke DS; Nisalak A; Gentry MK
    J Med Virol; 1987 Oct; 23(2):165-73. PubMed ID: 2445910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.